Zhang, C., Shen, L., Zhu, Y., Xu, R., Deng, Z., Liu, X., . . . Chen, S. (2021). KDM6A promotes imatinib resistance through YY1-mediated transcriptional upregulation of TRKA independently of its demethylase activity in chronic myelogenous leukemia. Theranostics.
Citação norma ChicagoZhang, Chengwan, et al. "KDM6A Promotes Imatinib Resistance Through YY1-mediated Transcriptional Upregulation of TRKA Independently of Its Demethylase Activity in Chronic Myelogenous Leukemia." Theranostics 2021.
Citação norma MLAZhang, Chengwan, et al. "KDM6A Promotes Imatinib Resistance Through YY1-mediated Transcriptional Upregulation of TRKA Independently of Its Demethylase Activity in Chronic Myelogenous Leukemia." Theranostics 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.